ArticleJournal of immunological methods2025

A high-throughput multi-species platform using Biolayer Interferometry Immunosorbent Assay (BLI-ISA) as an alternative to indirect ELISA for vaccine development.

Ti Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.